Robert Dickey work email
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
Robert Dickey personal email
- Valid
- Valid
Robert Dickey phone numbers
Demonstrated C-level (CFO, COO and CEO) and Board level experience in public, private, revenue stage and development stage life sciences and medical device companies and have played a leading role in 2 start-ups. Prior career as an investment banker, including 14 years at Lehman Brothers. Experienced in all stages of the business lifecycle, including start-up, high-growth and turnarounds and in building businesses and achieving an exit. Also international experience. Expertise in public and private financings, M&A, partnering/licensing transactions, project management and Chapter 11 reorganizations, as well as interacting with Boards, VC’s, shareholders and Wall Street. MBA from The Wharton School and an AB from Princeton University.
-
Managing DirectorForesite Advisors Mar 2020 - PresentFinancial advisory services for life science companies.
-
Chief Financial OfficerAim Immunotech Feb 2022 - PresentOcala, Fl, Us -
Chief Financial OfficerKenox Pharmaceuticals, Inc Dec 2021 - PresentMonmouth Junction, New Jersey, Us -
Chief Financial OfficerNeuyage May 2023 - Present
-
Member, Board Of DirectorsSfa Therapeutics Feb 2022 - PresentJenkintown, Pennsylvania, Us -
Chief Financial OfficerSfa Therapeutics Dec 2021 - PresentJenkintown, Pennsylvania, Us
-
Chief Financial OfficerSharp Edge Labs Feb 2021 - PresentPittsburgh, Pa, Us -
Interim Chief Financial OfficerVyome Therapeutics, Inc. Aug 2024 - PresentPrinceton, Nj, Us -
Member, Board Of DirectorsAngiogenex Inc Jun 2020 - Present -
Board MemberGsno Therapeutics Aug 2023 - Present
-
Chief Corporate Development OfficerBci Lifesciences Llc Mar 2021 - PresentNew York, New York, UsBroad advisory capabilities and has an investment banking partner, Bankers Capital International. -
Chief Financial OfficerApriligen, Inc. Jun 2020 - Sep 2024 -
Chief Financial OfficerNggt Inc. Aug 2023 - May 2024 -
Director Of FinanceVitruviae Jun 2021 - Feb 2023
-
Chief Financial OfficerSouth Rampart Pharma Aug 2021 - Aug 2022New Orleans, La, Us -
Chief Business OfficerSouth Rampart Pharma Aug 2021 - Aug 2022New Orleans, La, Us
-
Member, Board Of Directors And Audit Committee ChairmanEmmaus Life Sciences, Inc Sep 2018 - Aug 2022Torrance, Ca, Us -
Chief Financial OfficerMotif Bio Plc (Nasdaq:Mtfb) Jan 2017 - Feb 2018Motif Bio, dual listed on NASDAQ and the London AIM exchange, is engaged in the development of novel antibiotics for use against serious and life-threatening infections in hospitalized patients caused by multi-drug resistant bacteria.
-
Member, Board Of DirectorsSanuthera, Inc. 2013 - Dec 2017Sanuthera is a venture-backed, medical device company with an FDA approved therapy for tinnitus.
-
Chief Financial OfficerTyme Technologies, Inc. May 2015 - Jan 2017A publicly-traded, clinical stage oncology company with a therapy designed to create a metabolic response in tumor cells to alter the cell’s defenses. See: www.tymetechnologiesinc.com.
-
Chief Financial Officer (Part Time)Beyondspring Pharmaceuticals, Inc. Oct 2015 - Feb 2016A clinical stage oncology company with its most advanced program in a Phase III clinical study for non-small cell lung cancer. The company has significant Chinese connections and financial backing and its Phase III is being conducted principally in the US and China.
-
Chief Financial OfficerNeostem, Inc. Aug 2013 - Jan 2015Basking Ridge, Nj, UsNeoStem is a publicly-traded, revenue stage regenerative medicine company, principally focused on therapies involving adult stem cells. In May, 2014 we completed the acquisition of California Stem Cells, Inc. for total potential consideration, including milestone payments and royalties, of over $100 million. -
Senior Vice PresidentHemispherx Biopharma, Inc. Nov 2008 - Aug 2013Ocala, Florida, UsHemispherx was a publicly-traded company focused on therapeutics for Chronic Fatigue Syndrome, cancer and influenza. Responsibilities included evaluation of partnering/financing options and business development, special projects, grant writing, project management, International Operations and Human Resources. I was also Chairman of its Disclosure Controls Committee, responsible for all public disclosures, company-wide. -
Senior Vp, Cfo, And Business Unit ManagerStemcyte, Inc. Jul 2007 - Oct 2008Baldwin Park, Ca, UsStemCyte was a revenue stage, umbilical cord stem cell therapeutics company with operations in the US, Taiwan and India. My activities included finance, business development, IR/PR and overseeing a fast growing business unit. While there, I negotiated and completed a joint venture in India and a license agreement for the use of stem cells to treat Stroke. -
Vp, Finance And CfoLocus Pharmaceuticals Nov 2004 - Jun 2007UsLocus was a venture-backed, world leader in the use of supercomputers to design drugs and had collaborations with Amgen, Dow and Ono Pharmaceuticals. My activities included finance, fundraising, project management, business development, IR/PR, HR and Secretary to the Board. While there, I initiated and completed a $30 million equity raise and a Venture Debt financing. -
President, Coo, Ceo & CfoProtarga, Inc. 1996 - 2005I joined as the 4th employee of this company which grew to 60 people, a new cancer drug in Phase III clinical studies, and an IPO filed to go public. When the window for biotech IPO’s closed, I downsized the business, found additional financing and ultimately sold it to Daiichi Sankyo of Japan.
-
Managing DirectorLegg Mason Wood Walker 1992 - 1996San Mateo, California, UsInvestment Banking Department: IPO’s, secondary offerings, M&A and advisory services across various industries, including consumer goods, energy, high technology and healthcare. -
Senior Vice PresidentLehman Brothers 1985 - 1992UsInvestment Banking and M&A Departments: IPO’s, secondary offerings, M&A and advisory services across various industries. Senior VP of Lehman and then co-founder and Partner of an investment banking group within Lehman that provided M&A and financing advice to entrepreneurs. Acquired that business from Lehman and later sold it to Legg Mason Wood Walker.
Robert Dickey Skills
Robert Dickey Education Details
-
The Wharton SchoolFinance -
Princeton UniversityEconomics
-
Princeton UniversityEconomics
-
Princeton UniversityEconomics
-
Princeton UniversityEconomics
Frequently Asked Questions about Robert Dickey
What company does Robert Dickey work for?
Robert Dickey works for Aim Immunotech
What is Robert Dickey's role at the current company?
Robert Dickey's current role is Life Sciences CFO and Board Member.
What is Robert Dickey's email address?
Robert Dickey's email address is ro****@****aol.com
What is Robert Dickey's direct phone number?
Robert Dickey's direct phone number is +121524*****
What schools did Robert Dickey attend?
Robert Dickey attended The Wharton School, Princeton University, Princeton University, Princeton University, Princeton University.
What skills is Robert Dickey known for?
Robert Dickey has skills like Customer Service, Sales, Cannon, Hospitality, Start Ups, Mergers And Acquisitions, Ipo, Biotechnology, Business Development, Pharmaceutical Industry, Venture Capital, Entrepreneurship.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial